Literature DB >> 22186322

Lipid lowering effect of Cinnamomum zeylanicum in hyperlipidaemic albino rabbits.

Ijaz Javed1, Imran Faisal, Ziaur Rahman, Muhammad Zargham Khan, Faqir Muhammad, Bilal Aslam, Mahmood Ahmad, Andleeb Shahzadi.   

Abstract

The purpose of the present study was to investigate the lipid lowering effect of Cinnamomum zeylanicum (Cinnamon) in hyperlipidaemic albino rabbits. For this purpose, forty eight albino rabbits were randomly divided into eight equal groups; untreated control on normal routine feed, untreated control on butter and cholesterol, treated control on synthetic cholesterol lowering drug simvastatin (Tablet survive (R) 20 mg), three treated groups on three respective doses of C. zeylanicum bark powder and two treated groups on water and methanol extracts of C. zeylanicum bark powder. Butter ad lib and cholesterol powder 500 mg/kg body weight were used to induce experimental hyperlipidaemia in all groups except untreated control group. The results suggested that C. zeylanicum bark powder at the rate of 0.50 g/kg, 0.75 g/kg and methanol extract equivalent to 0.75 g/kg powder produced respective percent reductions in total lipids by 45, 49 and 64; triglycerides by 38, 53 and 60; total cholesterol by 53, 64 and 69 and LDL-cholesterol by 50, 59 and 62. However, at these dosage levels HDL-cholesterol showed respective percent increase of 42, 48 and 53. Nonetheless, C. zeylanicum bark powder at the level of 0.25g/kg and C. zeylanicum extract in water could not significantly reduce lipid profile indicators. Based on these studies, it can safely be said that C. zeylanicum bark powder methanol extract equivalent to 0.75g/kg bark powder and simvastatin (0.6 mg/kg b. wt.) were equieffective in treating hyperlipidaemia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22186322

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  7 in total

1.  Novel cinnamon-laden nanofibers as a potential antifungal coating for poly(methyl methacrylate) denture base materials.

Authors:  Juliana Silva Ribeiro; Ester Alves Ferreira Bordini; Gabriel Kalil Rocha Pereira; Rohitha Rao Polasani; Cristiane Helena Squarize; Karla Zanini Kantorski; Luiz Felipe Valandro; Marco Cícero Bottino
Journal:  Clin Oral Investig       Date:  2022-01-14       Impact factor: 3.573

Review 2.  Cinnamon: Mystic powers of a minute ingredient.

Authors:  Pallavi Kawatra; Rathai Rajagopalan
Journal:  Pharmacognosy Res       Date:  2015-06

Review 3.  Cinnamon effects on metabolic syndrome: a review based on its mechanisms.

Authors:  Hamid Mollazadeh; Hossein Hosseinzadeh
Journal:  Iran J Basic Med Sci       Date:  2016-12       Impact factor: 2.699

4.  Evaluation of pharmacodynamic properties and safety of Cinnamomum zeylanicum (Ceylon cinnamon) in healthy adults: a phase I clinical trial.

Authors:  Priyanga Ranasinghe; Ranil Jayawardena; Shehani Pigera; Wasundara Sevwandi Wathurapatha; Hasitha Dhananjaya Weeratunga; G A Sirimal Premakumara; Prasad Katulanda; Godwin Roger Constantine; Priyadarshani Galappaththy
Journal:  BMC Complement Altern Med       Date:  2017-12-28       Impact factor: 3.659

5.  Effects of cinnamon supplementation on antioxidant status and serum lipids in women with polycystic ovary syndrome.

Authors:  Azam Borzoei; Maryam Rafraf; Shirin Niromanesh; Laya Farzadi; Fateme Narimani; Farideh Doostan
Journal:  J Tradit Complement Med       Date:  2017-05-19

6.  Bark Extracts of Ceylon Cinnamon Possess Antilipidemic Activities and Bind Bile Acids In Vitro.

Authors:  Walimuni Prabhashini Kaushalya Mendis Abeysekera; Sirimal Premakumara Galbada Arachchige; Wanigasekera Daya Ratnasooriya
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-20       Impact factor: 2.629

Review 7.  Medicinal properties of 'true' cinnamon (Cinnamomum zeylanicum): a systematic review.

Authors:  Priyanga Ranasinghe; Shehani Pigera; G A Sirimal Premakumara; Priyadarshani Galappaththy; Godwin R Constantine; Prasad Katulanda
Journal:  BMC Complement Altern Med       Date:  2013-10-22       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.